Fidelity Investments’s Agios Pharmaceuticals AGIO Stock Holding History

Fidelity Investments’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$309K	Sell	9,121 -15,213	-63%	-$431K	﹤0.01%	3308
2025 Q4	$662K	Buy	24,334 +3,622	+17%	+$127K	﹤0.01%	2979
2025 Q3	$831K	Buy	20,712 +2,120	+11%	+$79.7K	﹤0.01%	2859
2025 Q2	$618K	Buy	18,592 +786	+4%	+$23.8K	﹤0.01%	2888
2025 Q1	$522K	Sell	17,806 -7,515	-30%	-$249K	﹤0.01%	2885
2024 Q4	$832K	Sell	25,321 -20,072	-44%	-$943K	﹤0.01%	2735
2024 Q3	$2.02M	Buy	45,393 +33,546	+283%	+$1.52M	﹤0.01%	2398
2024 Q2	$511K	Buy	11,847 +6,877	+138%	+$248K	﹤0.01%	2726
2024 Q1	$145K	Buy	4,970 +370	+8%	+$9.91K	﹤0.01%	3141
2023 Q4	$102K	Sell	4,600 -694	-13%	-$15.6K	﹤0.01%	3206
2023 Q3	$131K	Buy	5,294 +272	+5%	+$7.2K	﹤0.01%	3012
2023 Q2	$142K	Sell	5,022 -27	-0.5%	-$672	﹤0.01%	3045
2023 Q1	$116K	Sell	5,049 -1,635,265	-100%	-$43.4M	﹤0.01%	3158
2022 Q4	$46.1M	Sell	1,640,314 -266,240	-14%	-$7.5M	﹤0.01%	1285
2022 Q3	$53.9M	Sell	1,906,554 -1,029,288	-35%	-$27.6M	0.01%	1218
2022 Q2	$65.1M	Sell	2,935,842 -1,882,650	-39%	-$42.5M	0.01%	1138
2022 Q1	$140M	Sell	4,818,492 -615,822	-11%	-$18.8M	0.01%	932
2021 Q4	$179M	Sell	5,434,314 -1,414,504	-21%	-$56.9M	0.01%	850
2021 Q3	$316M	Sell	6,848,818 -1,233,192	-15%	-$59.6M	0.03%	612
2021 Q2	$445M	Buy	8,082,010 +203,105	+3%	+$11.4M	0.03%	478
2021 Q1	$407M	Buy	7,878,905 +3,540,238	+82%	+$175M	0.03%	503
2020 Q4	$188M	Buy	4,338,667 +509,781	+13%	+$20.2M	0.02%	769
2020 Q3	$134M	Sell	3,828,886 -1,787,441	-32%	-$78.3M	0.01%	793
2020 Q2	$300M	Sell	5,616,327 -3,379,252	-38%	-$156M	0.03%	459
2020 Q1	$319M	Buy	8,995,579 +167,117	+2%	+$7.72M	0.04%	362
2019 Q4	$422M	Buy	8,828,462 +15,530	+0.2%	+$587K	0.05%	377
2019 Q3	$286M	Buy	8,812,932 +6,232	+0.1%	+$258K	0.03%	492
2019 Q2	$439M	Buy	8,806,700 +47,387	+0.5%	+$2.53M	0.05%	361
2019 Q1	$591M	Buy	8,759,313 +32,512	+0.4%	+$1.89M	0.07%	271
2018 Q4	$402M	Buy	8,726,801 +27,915	+0.3%	+$1.72M	0.06%	347
2018 Q3	$671M	Buy	8,698,886 +58,043	+0.7%	+$4.67M	0.08%	249
2018 Q2	$728M	Buy	8,640,843 +41,832	+0.5%	+$3.65M	0.08%	224
2018 Q1	$703M	Buy	8,599,011 +1,289,268	+18%	+$99.7M	0.08%	256
2017 Q4	$418M	Buy	7,309,743 +51,064	+0.7%	+$3.21M	0.05%	406
2017 Q3	$485M	Buy	7,258,679 +31,348	+0.4%	+$1.88M	0.06%	337
2017 Q2	$372M	Buy	7,227,331 +895,584	+14%	+$45.8M	0.05%	423
2017 Q1	$370M	Buy	6,331,747 +32,931	+0.5%	+$1.58M	0.05%	426
2016 Q4	$263M	Buy	6,298,816 +87,744	+1%	+$4.6M	0.04%	553
2016 Q3	$328M	Buy	6,211,072 +526,304	+9%	+$22.9M	0.04%	465
2016 Q2	$238M	Buy	5,684,768 +10,684	+0.2%	+$528K	0.03%	591
2016 Q1	$230M	Buy	5,674,084 +27,989	+0.5%	+$1.2M	0.03%	588
2015 Q4	$367M	Buy	5,646,095 +29,542	+0.5%	+$1.94M	0.05%	412
2015 Q3	$396M	Buy	5,616,553 +21,828	+0.4%	+$2.13M	0.06%	370
2015 Q2	$622M	Buy	5,594,725 +11,957	+0.2%	+$1.29M	0.08%	278
2015 Q1	$526M	Buy	5,582,768 +88,420	+2%	+$9.91M	0.07%	330
2014 Q4	$616M	Buy	5,494,348 +243,889	+5%	+$21.8M	0.08%	281
2014 Q3	$322M	Buy	5,250,459 +158,813	+3%	+$6.85M	0.04%	448
2014 Q2	$233M	Buy	5,091,646 +1,450,967	+40%	+$59.1M	0.03%	608
2014 Q1	$143M	Buy	3,640,679 +1,409,114	+63%	+$47.1M	0.02%	794
2013 Q4	$53.4M	Hold	2,231,565	–	–	0.01%	1284
2013 Q3	$62.4M	Buy	+2,231,565	New	+$61.6M	0.01%	1178